{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T01:37:51Z","timestamp":1794620271271,"version":"4.9.1"},"reference-count":89,"publisher":"Oxford University Press (OUP)","issue":"Supplement_K","license":[{"start":{"date-parts":[[2019,12,17]],"date-time":"2019-12-17T00:00:00Z","timestamp":1576540800000},"content-version":"vor","delay-in-days":16,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Watermeadow Medical"},{"name":"Ashfield Company"},{"DOI":"10.13039\/100005646","name":"Actelion Pharmaceuticals Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005646","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Pulmonary arterial hypertension (PAH) is rare and, if untreated, has a median survival of 2\u20133\u2009years. Pulmonary arterial hypertension may be idiopathic (IPAH) but is frequently associated with other conditions. Despite increased awareness, therapeutic advances, and improved outcomes, the time from symptom onset to diagnosis remains unchanged. The commonest symptoms of PAH (breathlessness and fatigue) are non-specific and clinical signs are usually subtle, frequently preventing early diagnosis where therapies may be more effective. The failure to improve the time to diagnosis largely reflects an inability to identify patients at increased risk of PAH using current approaches. To date, strategies to improve the time to diagnosis have focused on screening patients with a high prevalence [systemic sclerosis (10%), patients with portal hypertension assessed for liver transplantation (2\u20136%), carriers of mutations of the gene encoding bone morphogenetic protein receptor type II, and first-degree relatives of patients with heritable PAH]. In systemic sclerosis, screening algorithms have demonstrated that patients can be identified earlier, however, current approaches are resource intensive. Until, recently, it has not been considered possible to screen populations for rare conditions such as IPAH (prevalence 5\u201315\/million\/year). However, there is interest in the use of artificial intelligence approaches in medicine and the application of diagnostic algorithms to large healthcare data sets, to identify patients at risk of rare conditions. In this article, we review current approaches and challenges in screening for PAH and explore novel population-based approaches to improve detection.<\/jats:p>","DOI":"10.1093\/eurheartj\/suz204","type":"journal-article","created":{"date-parts":[[2019,12,17]],"date-time":"2019-12-17T09:07:28Z","timestamp":1576573648000},"page":"K9-K20","source":"Crossref","is-referenced-by-count":74,"title":["Screening strategies for pulmonary arterial hypertension"],"prefix":"10.1093","volume":"21","author":[{"given":"David G","family":"Kiely","sequence":"first","affiliation":[{"name":"Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield, S10 2JF, UK"},{"name":"Department of Infection, Immunity & Cardiovascular Disease, University of Sheffield, Sheffield, S10 2RX, UK"},{"name":"Insigneo Institute for in silico Medicine, Sheffield, S1 3JD, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan","family":"Lawrie","sequence":"additional","affiliation":[{"name":"Department of Infection, Immunity & Cardiovascular Disease, University of Sheffield, Sheffield, S10 2RX, UK"},{"name":"Insigneo Institute for in silico Medicine, Sheffield, S1 3JD, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Humbert","sequence":"additional","affiliation":[{"name":"Univ. Paris\u2013Sud, Facult\u00e9 de M\u00e9decine, Universit\u00e9 Paris-Saclay, Le Kremlin Bic\u00eatre, France"},{"name":"AP-HP, Service de Pneumologie, Centre de R\u00e9f\u00e9rence de l\u2019Hypertension Pulmonaire, H\u00f4pital de Bic\u00eatre, Le Kremlin Bic\u00eatre, France"},{"name":"INSERM UMR_S 999, H\u00f4pital Marie Lannelongue, Le Plessis Robinson, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,12,17]]},"reference":[{"key":"2019121704072322600_suz204-B1","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/eurheartj\/ehv317","article-title":"2015 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: the Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT)","volume":"37","author":"Gali\u00e8","year":"2016","journal-title":"Eur Heart J"},{"key":"2019121704072322600_suz204-B2","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1183\/13993003.01032-2015","article-title":"2015 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: the Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): endorsed by: association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT)","volume":"46","author":"Gali\u00e8","year":"2015","journal-title":"Eur Respir J"},{"key":"2019121704072322600_suz204-B3","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/nhs.12138","article-title":"Impact of living with pulmonary hypertension: a qualitative exploration","volume":"16","author":"Yorke","year":"2014","journal-title":"Nurs Health Sci"},{"key":"2019121704072322600_suz204-B4","first-page":"28","article-title":"Which prognostic factors should be used in pulmonary arterial hypertension in elderly patients?","volume":"14","author":"Akdeniz","year":"2017","journal-title":"J Geriatr Cardiol"},{"key":"2019121704072322600_suz204-B5","doi-asserted-by":"crossref","first-page":"D51","DOI":"10.1016\/j.jacc.2013.10.023","article-title":"Pulmonary arterial hypertension: epidemiology and registries","volume":"62","author":"McGoon","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2019121704072322600_suz204-B6","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1183\/09059180.00007814","article-title":"The changing landscape of pulmonary arterial hypertension and implications for patient care","volume":"23","author":"Hoeper","year":"2014","journal-title":"Eur Respir Rev"},{"key":"2019121704072322600_suz204-B7","doi-asserted-by":"crossref","first-page":"1700740.","DOI":"10.1183\/13993003.00740-2017","article-title":"Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model","volume":"50","author":"Hoeper","year":"2017","journal-title":"Eur Respir J"},{"key":"2019121704072322600_suz204-B8","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1164\/rccm.201203-0383OC","article-title":"Changing demographics, epidemiology, and survival of incident pulmonary arterial hypertension: results from the pulmonary hypertension registry of the United Kingdom and Ireland","volume":"186","author":"Ling","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"2019121704072322600_suz204-B9","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1183\/09031936.00101211","article-title":"Survival in pulmonary hypertension in Spain: insights from the Spanish registry","volume":"40","author":"Escribano-Subias","year":"2012","journal-title":"Eur Respir J"},{"key":"2019121704072322600_suz204-B10","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.ijcard.2012.10.026","article-title":"Elderly patients diagnosed with idiopathic pulmonary arterial hypertension: results from the COMPERA registry","volume":"168","author":"Hoeper","year":"2013","journal-title":"Int J Cardiol"},{"key":"2019121704072322600_suz204-B11","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1378\/chest.15-0300","article-title":"Five-year outcomes of patients enrolled in the REVEAL registry","volume":"148","author":"Farber","year":"2015","journal-title":"Chest"},{"key":"2019121704072322600_suz204-B12","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1161\/CIRCULATIONAHA.109.911818","article-title":"Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era","volume":"122","author":"Humbert","year":"2010","journal-title":"Circulation"},{"key":"2019121704072322600_suz204-B13","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/acr.22121","article-title":"Survival and predictors of mortality in systemic sclerosis-associated pulmonary arterial hypertension: outcomes from the pulmonary hypertension assessment and recognition of outcomes in scleroderma registry","volume":"66","author":"Chung","year":"2014","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2019121704072322600_suz204-B14","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.1002\/art.30541","article-title":"Screening for pulmonary arterial hypertension in patients with systemic sclerosis: clinical characteristics at diagnosis and long-term survival","volume":"63","author":"Humbert","year":"2011","journal-title":"Arthritis Rheum"},{"key":"2019121704072322600_suz204-B15","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1183\/09031936.00072709","article-title":"Survival in pulmonary arterial hypertension: a reappraisal of the NIH risk stratification equation","volume":"35","author":"Thenappan","year":"2010","journal-title":"Eur Respir J"},{"key":"2019121704072322600_suz204-B16","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1161\/CIRCULATIONAHA.109.898122","article-title":"Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL)","volume":"122","author":"Benza","year":"2010","journal-title":"Circulation"},{"key":"2019121704072322600_suz204-B17","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/S0140-6736(08)60919-8","article-title":"Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial","volume":"371","author":"Gali\u00e8","year":"2008","journal-title":"Lancet"},{"key":"2019121704072322600_suz204-B18","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1136\/annrheumdis-2013-203301","article-title":"Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study","volume":"73","author":"Coghlan","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"2019121704072322600_suz204-B19","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/17476348.2018.1420478","article-title":"Current and emerging imaging techniques in the diagnosis and assessment of pulmonary hypertension","volume":"12","author":"Johns","year":"2018","journal-title":"Expert Rev Respir Med"},{"key":"2019121704072322600_suz204-B20","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3389\/fmed.2018.00175","article-title":"Circulating protein biomarkers in systemic sclerosis related pulmonary arterial hypertension: a review of published data","volume":"5","author":"Hickey","year":"2018","journal-title":"Front Med (Lausanne)"},{"key":"2019121704072322600_suz204-B21","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ahj.2018.11.001","article-title":"The prognostic value of various biomarkers in adults with pulmonary hypertension; a multi-biomarker approach","volume":"208","author":"Geenen","year":"2019","journal-title":"Am Heart J"},{"key":"2019121704072322600_suz204-B22","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1161\/CIRCULATIONAHA.108.800938","article-title":"Stress Doppler echocardiography in relatives of patients with idiopathic and familial pulmonary arterial hypertension: results of a multicenter European analysis of pulmonary artery pressure response to exercise and hypoxia","volume":"119","author":"Grunig","year":"2009","journal-title":"Circulation"},{"key":"2019121704072322600_suz204-B23","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.chest.2019.02.004","article-title":"Predicting survival in patients with pulmonary arterial hypertension: the REVEAL risk score calculator 2.0 and comparison with ESC\/ERS-based risk assessment strategies","volume":"156","author":"Benza","year":"2019","journal-title":"Chest"},{"key":"2019121704072322600_suz204-B24","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1164\/rccm.200510-1668OC","article-title":"Pulmonary arterial hypertension in France: results from a national registry","volume":"173","author":"Humbert","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"2019121704072322600_suz204-B25","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.rmed.2010.01.002","article-title":"Burden of pulmonary arterial hypertension in Germany","volume":"104","author":"Wilkens","year":"2010","journal-title":"Respir Med"},{"key":"2019121704072322600_suz204-B26","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1378\/chest.10-1166","article-title":"Delay in recognition of pulmonary arterial hypertension: factors identified from the REVEAL Registry","volume":"140","author":"Brown","year":"2011","journal-title":"Chest"},{"key":"2019121704072322600_suz204-B27","doi-asserted-by":"crossref","first-page":"204589401879861.","DOI":"10.1177\/2045894018798613","article-title":"High levels of healthcare utilization prior to diagnosis in idiopathic pulmonary arterial hypertension support the feasibility of an early diagnosis algorithm: the SPHInX project","volume":"8","author":"Bergemann","year":"2018","journal-title":"Pulm Circ"},{"key":"2019121704072322600_suz204-B28","doi-asserted-by":"crossref","first-page":"89","DOI":"10.4103\/2045-8932.109919","article-title":"Time from symptoms to definitive diagnosis of idiopathic pulmonary arterial hypertension: the delay study","volume":"3","author":"Strange","year":"2013","journal-title":"Pulm Circ"},{"key":"2019121704072322600_suz204-B29","doi-asserted-by":"crossref","first-page":"67.","DOI":"10.1186\/s12890-019-0827-5","article-title":"The patient experience of pulmonary hypertension: a large cross-sectional study of UK patients","volume":"19","author":"Armstrong","year":"2019","journal-title":"BMC Pulm Med"},{"key":"2019121704072322600_suz204-B30"},{"key":"2019121704072322600_suz204-B31","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.1002\/art.38172","article-title":"Recommendations for screening and detection of connective tissue disease-associated pulmonary arterial hypertension","volume":"65","author":"Khanna","year":"2013","journal-title":"Arthritis Rheum"},{"key":"2019121704072322600_suz204-B32","doi-asserted-by":"crossref","first-page":"00135","DOI":"10.1183\/23120541.00135-2017","article-title":"Rationale and design of the screening of pulmonary hypertension in systemic lupus erythematosus (SOPHIE) study","volume":"4","author":"Huang","year":"2018","journal-title":"ERJ Open Res"},{"key":"2019121704072322600_suz204-B33","doi-asserted-by":"crossref","first-page":"1801913.","DOI":"10.1183\/13993003.01913-2018","article-title":"Haemodynamic definitions and updated clinical classification of pulmonary hypertension","volume":"53","author":"Simonneau","year":"2019","journal-title":"Eur Respir J"},{"key":"2019121704072322600_suz204-B34","doi-asserted-by":"crossref","first-page":"1801899.","DOI":"10.1183\/13993003.01899-2018","article-title":"Genetics and genomics of pulmonary arterial hypertension","volume":"53","author":"Morrell","year":"2019","journal-title":"Eur Respir J"},{"key":"2019121704072322600_suz204-B35","doi-asserted-by":"crossref","first-page":"1416.","DOI":"10.1038\/s41467-018-03672-4","article-title":"Identification of rare sequence variation underlying heritable pulmonary arterial hypertension","volume":"9","author":"Graf","year":"2018","journal-title":"Nat Commun"},{"key":"2019121704072322600_suz204-B36","doi-asserted-by":"crossref","first-page":"87.","DOI":"10.1186\/s12931-018-0789-9","article-title":"Genetic analyses in a cohort of 191 pulmonary arterial hypertension patients","volume":"19","author":"Yang","year":"2018","journal-title":"Respir Res"},{"key":"2019121704072322600_suz204-B37","first-page":"A7364","article-title":"The UK National Cohort Study of idiopathic and heritable pulmonary arterial hypertension","volume":"193","author":"Blenda","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"2019121704072322600_suz204-B38","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/0016-5085(91)90225-A","article-title":"Pulmonary hypertension complicating portal hypertension: prevalence and relation to splanchnic hemodynamics","volume":"100","author":"Hadengue","year":"1991","journal-title":"Gastroenterology"},{"key":"2019121704072322600_suz204-B39","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1164\/rccm.200704-541OC","article-title":"Prevalence of HIV-related pulmonary arterial hypertension in the current antiretroviral therapy era","volume":"177","author":"Sitbon","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"2019121704072322600_suz204-B40","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.ijcard.2014.04.072","article-title":"Contemporary prevalence of pulmonary arterial hypertension in adult congenital heart disease following the updated clinical classification","volume":"174","author":"van Riel","year":"2014","journal-title":"Int J Cardiol"},{"key":"2019121704072322600_suz204-B41","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1016\/j.jacc.2019.03.482","article-title":"Threshold of pulmonary hypertension associated with increased mortality","volume":"73","author":"Strange","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2019121704072322600_suz204-B42","doi-asserted-by":"crossref","first-page":"4058","DOI":"10.1016\/j.ijcard.2013.07.005","article-title":"Accuracy and precision of echocardiography versus right heart catheterization for the assessment of pulmonary hypertension","volume":"168","author":"D'Alto","year":"2013","journal-title":"Int J Cardiol"},{"key":"2019121704072322600_suz204-B43","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/ehjci\/jev014","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"16","author":"Lang","year":"2015","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2019121704072322600_suz204-B44","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/art.10775","article-title":"Predictors of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvement","volume":"48","author":"Steen","year":"2003","journal-title":"Arthritis Rheum"},{"key":"2019121704072322600_suz204-B45","doi-asserted-by":"crossref","first-page":"3792","DOI":"10.1002\/art.21433","article-title":"Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study","volume":"52","author":"Hachulla","year":"2005","journal-title":"Arthritis Rheum"},{"key":"2019121704072322600_suz204-B46","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/S0735-1097(02)02964-9","article-title":"Pulmonary function in primary pulmonary hypertension","volume":"41","author":"Sun","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"2019121704072322600_suz204-B47","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1183\/09031936.00184412","article-title":". Severely reduced diffusion capacity in idiopathic pulmonary arterial hypertension: patient characteristics and treatment responses","volume":"42","author":"Trip","year":"2013","journal-title":"Eur Respir J"},{"key":"2019121704072322600_suz204-B48","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3389\/fmed.2018.00172","article-title":"Incremental shuttle walking test distance is reduced in patients with pulmonary hypertension in World Health Organisation Functional Class I","volume":"5","author":"Billings","year":"2018","journal-title":"Front Med (Lausanne)"},{"key":"2019121704072322600_suz204-B49","doi-asserted-by":"crossref","first-page":"R193.","DOI":"10.1186\/ar4383","article-title":"The inclusion of N-terminal pro-brain natriuretic peptide in a sensitive screening strategy for systemic sclerosis-related pulmonary arterial hypertension: a cohort study","volume":"15","author":"Thakkar","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"2019121704072322600_suz204-B50","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1016\/j.jacc.2017.08.012","article-title":"Cardiopulmonary exercise testing: what is its value?","volume":"70","author":"Guazzi","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2019121704072322600_suz204-B51","doi-asserted-by":"crossref","first-page":"190023.","DOI":"10.1183\/16000617.0023-2019","article-title":"Screening for pulmonary arterial hypertension in systemic sclerosis","volume":"28","author":"Weatherald","year":"2019","journal-title":"Eur Respir Rev"},{"key":"2019121704072322600_suz204-B52","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1164\/rccm.167.2.211","article-title":"ATS\/ACCP statement on cardiopulmonary exercise testing","volume":"167","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"2019121704072322600_suz204-B53","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1177\/1741826711426635","article-title":"Exercise testing in the clinical management of patients affected by pulmonary arterial hypertension","volume":"19","author":"Paolillo","year":"2012","journal-title":"Eur J Prev Cardiol"},{"key":"2019121704072322600_suz204-B54","doi-asserted-by":"crossref","first-page":"170134.","DOI":"10.1183\/16000617.0134-2017","article-title":"The role of cardiopulmonary exercise tests in pulmonary arterial hypertension","volume":"27","author":"Farina","year":"2018","journal-title":"Eur Respir Rev"},{"key":"2019121704072322600_suz204-B55","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1513\/AnnalsATS.201412-558CC","article-title":"Exercise intolerance in pulmonary arterial hypertension. The role of cardiopulmonary exercise testing","volume":"12","author":"Neder","year":"2015","journal-title":"Ann Am Thorac Soc"},{"key":"2019121704072322600_suz204-B56","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1136\/heartjnl-2016-309981","article-title":"Cardiopulmonary exercise testing for detecting pulmonary arterial hypertension in systemic sclerosis","volume":"103","author":"Dumitrescu","year":"2017","journal-title":"Heart"},{"key":"2019121704072322600_suz204-B57","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/clc.22635","article-title":"Cardiopulmonary exercise testing improves diagnostic specificity in patients with echocardiography-suspected pulmonary hypertension","volume":"40","author":"Zhao","year":"2017","journal-title":"Clin Cardiol"},{"key":"2019121704072322600_suz204-B58","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.ijcard.2014.04.156","article-title":"Blood biomarkers and their potential role in pulmonary arterial hypertension associated with congenital heart disease. a systematic review","volume":"174","author":"Giannakoulas","year":"2014","journal-title":"Int J Cardiol"},{"key":"2019121704072322600_suz204-B59","doi-asserted-by":"crossref","first-page":"556.","DOI":"10.1007\/s11906-015-0556-y","article-title":"Biomarkers and prognostic indicators in pulmonary arterial hypertension","volume":"17","author":"Jardim","year":"2015","journal-title":"Curr Hypertens Rep"},{"key":"2019121704072322600_suz204-B60","doi-asserted-by":"crossref","first-page":"491","DOI":"10.2174\/1389201018666170615082510","article-title":"An expanding role of biomarkers in pulmonary arterial hypertension","volume":"18","author":"Yildiz","year":"2017","journal-title":"Curr Pharm Biotechnol"},{"key":"2019121704072322600_suz204-B61","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1183\/09031936.00095606","article-title":"NT-proBNP can be used to detect right ventricular systolic dysfunction in pulmonary hypertension","volume":"29","author":"Blyth","year":"2007","journal-title":"Eur Respir J"},{"key":"2019121704072322600_suz204-B62","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1378\/chest.129.5.1313","article-title":"Serum N-terminal brain natriuretic peptide as a prognostic parameter in patients with pulmonary hypertension","volume":"129","author":"Fijalkowska","year":"2006","journal-title":"Chest"},{"key":"2019121704072322600_suz204-B63","doi-asserted-by":"crossref","first-page":"D60","DOI":"10.1016\/j.jacc.2013.10.031","article-title":"Updated treatment algorithm of pulmonary arterial hypertension","volume":"62","author":"Gali\u00e8","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2019121704072322600_suz204-B64","first-page":"e37","article-title":"Relationship between serum uric acid levels and ventricular function in patients with idiopathic pulmonary hypertension","volume":"18","author":"Zhang","year":"2013","journal-title":"Exp Clin Cardiol"},{"key":"2019121704072322600_suz204-B65","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00296-010-1557-4","article-title":"Significance of serum uric acid in pulmonary hypertension due to systemic sclerosis: a pilot study","volume":"31","author":"Dimitroulas","year":"2011","journal-title":"Rheumatol Int"},{"key":"2019121704072322600_suz204-B66","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1164\/ajrccm.160.2.9812078","article-title":"Serum uric acid levels correlate with the severity and the mortality of primary pulmonary hypertension","volume":"160","author":"Nagaya","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"2019121704072322600_suz204-B67","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1164\/rccm.201802-0375OC","article-title":"Detection of pediatric pulmonary arterial hypertension by school electrocardiography mass screening","volume":"199","author":"Sawada","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"2019121704072322600_suz204-B68","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nrcardio.2014.191","article-title":"Early detection of pulmonary arterial hypertension","volume":"12","author":"Lau","year":"2015","journal-title":"Nat Rev Cardiol"},{"key":"2019121704072322600_suz204-B69","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1111\/imj.12167","article-title":"Performance of screening algorithms in systemic sclerosis-related pulmonary arterial hypertension: a systematic review","volume":"43","author":"Thakkar","year":"2013","journal-title":"Intern Med J"},{"key":"2019121704072322600_suz204-B70","first-page":"K37","article-title":"Pulmonary arterial hypertension populations of special interest: portopulmonary hypertension and pulmonary arterial hypertension associated with congenital heart disease","volume-title":"Eur Heart J Suppl","author":"Savale","year":"2019"},{"key":"2019121704072322600_suz204-B71","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1016\/j.jacc.2018.08.2201","article-title":"Echocardiographic screening for pulmonary hypertension in congenital heart disease: JACC review topic of the week","volume":"72","author":"Dimopoulos","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2019121704072322600_suz204-B72","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1111\/echo.14349","article-title":"Echocardiographic assessment of pulmonary arterial stiffness in human immunodeficiency virus-infected patients","volume":"36","author":"Cerik","year":"2019","journal-title":"Echocardiography"},{"key":"2019121704072322600_suz204-B73","first-page":"92","article-title":"A new echocardiographic approach in assessing pulmonary vascular bed in patients with congenital heart disease: pulmonary artery stiffness","volume":"3","author":"Gorgulu","year":"2003","journal-title":"Anadolu Kardiyol Derg"},{"key":"2019121704072322600_suz204-B74","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1111\/imj.12890","article-title":"Cost savings with a new screening algorithm for pulmonary arterial hypertension in systemic sclerosis","volume":"45","author":"Quinlivan","year":"2015","journal-title":"Intern Med J"},{"key":"2019121704072322600_suz204-B75","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1164\/rccm.201812-2314ED","article-title":"Early diagnosis in pulmonary arterial hypertension: the search for the holy grail","volume":"199","author":"Berger","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"2019121704072322600_suz204-B76","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1165\/rcmb.2014-0166TR","article-title":"MicroRNAs in pulmonary arterial hypertension","volume":"52","author":"Zhou","year":"2015","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2019121704072322600_suz204-B77","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/B978-0-12-386930-2.00003-3","article-title":"MicroRNA in pulmonary vascular disease","volume":"124","author":"Rothman","year":"2014","journal-title":"Prog Mol Biol Transl Sci"},{"key":"2019121704072322600_suz204-B78","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1164\/rccm.201205-0839OC","article-title":"Reduced microRNA-150 is associated with poor survival in pulmonary arterial hypertension","volume":"187","author":"Rhodes","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"2019121704072322600_suz204-B79","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1172\/JCI83361","article-title":"MicroRNA-140-5p and SMURF1 regulate pulmonary arterial hypertension","volume":"126","author":"Rothman","year":"2016","journal-title":"J Clin Invest"},{"key":"2019121704072322600_suz204-B80","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S2213-2600(17)30161-3","article-title":"Plasma proteome analysis in patients with pulmonary arterial hypertension: an observational cohort study","volume":"5","author":"Rhodes","year":"2017","journal-title":"Lancet Respir Med"},{"key":"2019121704072322600_suz204-B81","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1161\/CIRCULATIONAHA.116.024602","article-title":"Plasma metabolomics implicates modified transfer RNAs and altered bioenergetics in the outcomes of pulmonary arterial hypertension","volume":"135","author":"Rhodes","year":"2017","journal-title":"Circulation"},{"key":"2019121704072322600_suz204-B82","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1378\/chest.11-0676","article-title":"The REVEAL Registry risk score calculator in patients newly diagnosed with pulmonary arterial hypertension","volume":"141","author":"Benza","year":"2012","journal-title":"Chest"},{"key":"2019121704072322600_suz204-B83","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1164\/rccm.201303-0467LE","article-title":"A proof of concept for the detection and classification of pulmonary arterial hypertension through breath analysis with a sensor array","volume":"188","author":"Cohen-Kaminsky","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"2019121704072322600_suz204-B84","doi-asserted-by":"crossref","first-page":"1601897.","DOI":"10.1183\/13993003.01897-2016","article-title":"Volatolomics of breath as an emerging frontier in pulmonary arterial hypertension","volume":"49","author":"Nakhleh","year":"2017","journal-title":"Eur Respir J"},{"key":"2019121704072322600_suz204-B85","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1021\/acsnano.6b04930","article-title":"Diagnosis and classification of 17 diseases from 1404 subjects via pattern analysis of exhaled molecules","volume":"11","author":"Nakhleh","year":"2017","journal-title":"ACS Nano"},{"key":"2019121704072322600_suz204-B86","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1164\/rccm.201802-0317LE","article-title":"Natural history over 8 years of pulmonary vascular disease in a patient carrying biallelic EIF2AK4 mutations","volume":"198","author":"Montani","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"2019121704072322600_suz204-B87","doi-asserted-by":"crossref","DOI":"10.1177\/2045894019841990","article-title":"EXPRESS: statement on imaging and pulmonary hypertension from the Pulmonary Vascular Research Institute (PVRI)","author":"Kiely","year":"2019","journal-title":"Pulm Circ"},{"key":"2019121704072322600_suz204-B88","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1136\/thoraxjnl-2014-206088","article-title":"CT features of pulmonary arterial hypertension and its major subtypes: a systematic CT evaluation of 292 patients from the ASPIRE Registry","volume":"70","author":"Rajaram","year":"2015","journal-title":"Thorax"},{"key":"2019121704072322600_suz204-B89","doi-asserted-by":"crossref","first-page":"35.","DOI":"10.1186\/s41747-018-0061-6","article-title":"Artificial intelligence in medical imaging: threat or opportunity? Radiologists again at the forefront of innovation in medicine","volume":"2","author":"Pesapane","year":"2018","journal-title":"Eur Radiol Exp"}],"container-title":["European Heart Journal Supplements"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/eurheartjsupp\/article-pdf\/21\/Supplement_K\/K9\/31538861\/suz204.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/eurheartjsupp\/article-pdf\/21\/Supplement_K\/K9\/31538861\/suz204.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,17]],"date-time":"2019-12-17T09:08:03Z","timestamp":1576573683000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartjsupp\/article\/21\/Supplement_K\/K9\/5678711"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,1]]},"references-count":89,"journal-issue":{"issue":"Supplement_K","published-online":{"date-parts":[[2019,12,17]]},"published-print":{"date-parts":[[2019,12,1]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/suz204","relation":{},"ISSN":["1520-765X","1554-2815"],"issn-type":[{"value":"1520-765X","type":"print"},{"value":"1554-2815","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,12]]},"published":{"date-parts":[[2019,12,1]]}}}